A method to estimate composite doses for organs at risk in prostate cancer patients treated with EBRT in combination with HDR BT

References

• Hoskin PJ, Colombo A, Henry A, Niehoff P, Paulsen Hellebust T, Siebert FA, et al. GEC/ESTRO recommendations on high dose rate afterloading brachytherapy for localised prostate cancer: An update. Radiother Oncol 2013;107:325–32.
   PubMed Web of Science ®Google Scholar
• Borghede G, Hedelin H, Holmang S, Johansson KA, Sernbo G, Mercke C. Irradiation of localized prostatic carcinoma with a combination of high dose rate iridium-192 brachytherapy and external beam radiotherapy with three target definitions and dose levels inside the prostate gland. Radiother Oncol 1997;44:245–50.
   PubMed Web of Science ®Google Scholar
• Rivard MJ, Coursey BM, DeWerd LA, Hanson WF, Huq MS, Ibbott GS, et al. Update of AAPM task group no. 43 report: A revised AAPM protocol for brachytherapy dose calculations. Med Phys 2004;31:633–74.
   PubMed Web of Science ®Google Scholar
• Alsadius D, Hedelin M, Johansson KA, Pettersson N, Wilderang U, Lundstedt D, et al. Tobacco smoking and long-lasting symptoms from the bowel and the anal-sphincter region after radiotherapy for prostate cancer. Radiother Oncol 2011;101:495–501.
   PubMed Web of Science ®Google Scholar
• Waldenstrom AC, Alsadius D, Pettersson N, Johansson KA, Holmberg E, Steineck G, et al. Variation in position and volume of organs at risk in the small pelvis. Acta Oncol 2010;49:491–9.
   PubMed Web of Science ®Google Scholar
• ICRU Report 58, Dose and volume specification for reporting interstitial brachytherapy. Bethesda, MD: International Commission on Radiation Units and Measurements; 1997.
   Google Scholar
• ICRU Report 83, Prescribing, recording, and reporting photon beam intensity-modulated radiation therapy (IMRT). Bethesda, MD: International Commission on Radiation Units and Measurements; 2010.
   Google Scholar
• Kovacs G, Potter R, Loch T, Hammer J, Kolkman-Deurloo IK, de la Rosette JJ, et al. GEC/ESTRO-EAU recommendations on temporary brachytherapy using stepping sources for localised prostate cancer. Radiother Oncol 2005;74:137–48.
   PubMed Web of Science ®Google Scholar
• Potter R, Haie-Meder C, Van Limbergen E, Barillot I, De Brabandere M, Dimopoulos J, et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol 2006;78:67–77.
   PubMed Web of Science ®Google Scholar
• Marks LB, Yorke ED, Jackson A, Ten Haken RK, Constine LS, Eisbruch A, et al. Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys 2010;76(3 Suppl):S10–9.
   PubMed Web of Science ®Google Scholar
• Bentzen SM, Dorr W, Gahbauer R, Howell RW, Joiner MC, Jones B, et al. Bioeffect modeling and equieffective dose concepts in radiation oncology – terminology, quantities and units. Radiother Oncol 2012;105:266–8.
   PubMed Web of Science ®Google Scholar
• Das IJ, Andrews JZ, Cao M, Johnstone PA. Correlation of 2D parameters to lung and heart dose-volume in radiation treatment of breast cancer. Acta Oncol 2013;52:178–83.
   PubMed Web of Science ®Google Scholar
• Ng A, Brock KK, Sharpe MB, Moseley JL, Craig T, Hodgson DC. Individualized 3D reconstruction of normal tissue dose for patients with long-term follow-up: A step toward understanding dose risk for late toxicity. Int J Radiat Oncol Biol Phys 2012;84:e557–63.
   Web of Science ®Google Scholar
• Teh AY, Park EJ, Shen L, Chung HT. Three-dimensional volumetric analysis of irradiated lung with adjuvant breast irradiation. Int J Radiat Oncol Biol Phys 2009;75: 1309–15.
   PubMed Web of Science ®Google Scholar
• Taylor CW, Nisbet A, McGale P, Darby SC. Cardiac exposures in breast cancer radiotherapy: 1950s–1990s. Int J Radiat Oncol Biol Phys 2007;69:1484–95.
   PubMed Web of Science ®Google Scholar
• Hsu IC, Pickett B, Shinohara K, Krieg R, Roach M, 3rd, Phillips T. Normal tissue dosimetric comparison between HDR prostate implant boost and conformal external beam radiotherapy boost: Potential for dose escalation. Int J Radiat Oncol Biol Phys 2000;46:851–8.
   PubMed Web of Science ®Google Scholar
• Lachance B, Beliveau-Nadeau D, Lessard E, Chretien M, Hsu IC, Pouliot J, et al. Early clinical experience with anatomy-based inverse planning dose optimization for high-dose-rate boost of the prostate. Int J Radiat Oncol Biol Phys 2002;54:86–100.
   PubMed Web of Science ®Google Scholar
• Pouliot J, Kim Y, Lessard E, Hsu IC, Vigneron DB, Kurhanewicz J. Inverse planning for HDR prostate brachytherapy used to boost dominant intraprostatic lesions defined by magnetic resonance spectroscopy imaging. Int J Radiat Oncol Biol Phys 2004;59:1196–207.
   PubMed Web of Science ®Google Scholar
• Jaffray DA, Lindsay PE, Brock KK, Deasy JO, Tome WA. Accurate accumulation of dose for improved understanding of radiation effects in normal tissue. Int J Radiat Oncol Biol Phys 2010;76(3 Suppl):S135–9.
   Web of Science ®Google Scholar
• Allen Li X, Alber M, Deasy JO, Jackson A, Ken Jee KW, Marks LB, et al. The use and QA of biologically related models for treatment planning: Short report of the TG-166 of the therapy physics committee of the AAPM. Med Phys 2012;39:1386–409.
   PubMed Web of Science ®Google Scholar